Susan Kelliher - Chemours President
CC Stock | USD 28.90 0.47 1.65% |
President
Ms. Susan M. Kelliher is Senior Vice President Human Resources and Health Services of the company. Ms. Kelliher joined Chemours in 2017 from Albemarle Corporation, where she served as Senior Vice President Human Resources for the global specialty chemical company. Prior to Albemarle, she served as Vice President Human Resources at Hewlett Packard, where she held a number of leadership positions on global teams including Imaging and Printing and Global Sales and Enterprise Marketing from 2007 to 2012. Before joining Hewlett Packard, Ms. Kelliher served as Vice President Human Resources for Cymer, Inc., where she led the people function. She joined Cymer from The Home Depot where, from 2004 to 2007, she was the Vice President Human Resources for the growth engines of the company Business Development and Home Services including responsibility for due diligence and integration for the companys acquisitions. From 2000 to 2004, Ms. Kelliher served as Senior Director of Human Resources for Corporationrationrate Business Development and International Operations for the Raytheon Company . Prior to Raytheon, she served as the Director of Human Resources Western Region for YUM Brands, Pizza Hut division from 1995 to 2000. Ms. Kelliher started her career at Mobil Oil, where her career progressed through a variety of assignments including support for new ventures in Europe, Russia, and Africa from 1990 to 1995. since 2017.
Age | 57 |
Tenure | 7 years |
Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
Phone | 302 773 1000 |
Web | https://www.chemours.com |
Chemours Management Efficiency
The company has Return on Asset (ROA) of 0.0457 % which means that for every $100 of assets, it generated a profit of $0.0457. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.333) %, which implies that it produced no returns to current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.01. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.11, whereas Total Assets are forecasted to decline to about 7.5 B.Similar Executives
Showing other executives | PRESIDENT Age | ||
Jan Nieman | Quaker Chemical | 56 | |
David Slinkman | Quaker Chemical | 59 | |
Wilbert Platzer | Quaker Chemical | 63 | |
Jessica Moskowitz | Oil Dri | 41 | |
Dieter Laininger | Quaker Chemical | 57 | |
Anne Schumann | Ashland Global Holdings | 58 | |
John Willis | Ashland Global Holdings | 59 | |
Adrian Steeples | Quaker Chemical | 60 | |
Aaron Christiansen | Oil Dri | 47 | |
Mary Hall | Quaker Chemical | 62 | |
Yvonne Mohrenfels | Ashland Global Holdings | 58 | |
Keith Silverman | Ashland Global Holdings | 51 | |
Osama Musa | Ashland Global Holdings | 56 | |
Joseph Matrange | Quaker Chemical | 74 | |
Joseph Berquist | Quaker Chemical | 53 |
Management Performance
Return On Equity | -0.33 | |||
Return On Asset | 0.0457 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
Dawn Farrell, Independent Chairman of the Board | ||
Curtis Anastasio, Independent Director | ||
Jonathan Lock, Senior Vice President and Chief Development Officer | ||
Amber Wellman, Chief Officer | ||
Matthew Abbott, Vice President - Digital and Analytics Platforms Leader | ||
David Shelton, Senior Vice President, General Counsel, Secretary | ||
Denise Dignam, President - Advanced Performance Materials | ||
Curtis Crawford, Independent Director | ||
Aditya Beri, Interim Business | ||
Mary Cranston, Independent Director | ||
Bradley Bell, Independent Director | ||
Sheryl Telford, Chief Sustainability Officer | ||
Ron Charles, Senior People | ||
Erin Kane, Independent Director | ||
Alisha Bellezza, President - Thermal & Specialized Solutions | ||
Joseph Martinko, President Solutions | ||
Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
Gerardo Calderon, President Materials | ||
Eugene Snell, President - Titanium Technologies | ||
Sandra Rogers, Independent Director | ||
Kurt Bonner, Ma Relations | ||
Kristine Wellman, General VP | ||
Sean Keohane, Independent Director | ||
Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer | ||
Guillaume Pepy, Independent Director | ||
Brandon Ontjes, Vice Relations | ||
Camela Wisel, Chief Accounting Officer, Vice President Controller | ||
Mark Newman, Chief Operating Officer, Senior Vice President | ||
Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies | ||
Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer. | ||
Mark Vergnano, President, Chief Executive Officer, Director | ||
Richard Brown, Independent Chairman of the Board | ||
Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.33 | |||
Return On Asset | 0.0457 | |||
Profit Margin | (0.06) % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 7.82 B | |||
Shares Outstanding | 148.9 M | |||
Shares Owned By Insiders | 0.59 % | |||
Shares Owned By Institutions | 74.66 % | |||
Number Of Shares Shorted | 5.73 M | |||
Price To Earning | 25.49 X |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share (2.22) | Revenue Per Share 39.222 | Quarterly Revenue Growth (0.12) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.